Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Rhythm Pharmaceuticals, Inc. (RYTM) had Free Cash Flow per Share of $-0.65 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$60.11M |
|
$-56.74M |
|
$7.16M |
|
$52.95M |
|
$112.47M |
|
$-52.36M |
|
$-2.73M |
|
$-55.09M |
|
$-55.09M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-52.36M |
|
$-52.11M |
|
67.97M |
|
67.97M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$430.09M |
|
$1.06M |
|
$12.23M |
|
$442.32M |
|
$103.20M |
|
-- |
|
$101.50M |
|
$204.70M |
|
$122.91M |
|
$232.51M |
|
$237.62M |
|
68.44M |
|
| Cash Flow Statement Financials | |
$-44.19M |
|
$57.05M |
|
$-5.40M |
|
$54.82M |
|
$62.74M |
|
$7.92M |
|
$23.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
88.09% |
|
-87.11% |
|
-87.11% |
|
-- |
|
-91.65% |
|
-94.40% |
|
$-44.19M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.25 |
|
1.76 |
|
51.19 |
|
-45.27% |
|
-23.93% |
|
-12.58% |
|
-23.42% |
|
$3.47 |
|
|
Free Cash Flow per Share |
$-0.65 |
$-0.65 |
|